Chapter 3: Doctors need to “unlearn” nutrition — References
Page 49
| “to do this effectively” |
| J.L. Turton et al. ” Low-Carbohydrate Diets for Type 1 Diabetes Mellitus: A Systematic Review,” PLoS One 13 (3) (2018): e0194987. |
| “message in public in” |
| R.H. Lustig. “Sugar: The Bitter Truth”. UCSF Mini-Med School for the Public. (San Diego: UCTV, 2009). |
| “National Bureau of Economic Research put it to the test” |
| P. Azoulay et al. “Does Science Advance One Funeral at a Time?,” Am. Econ. Rev. 109 (8) (2019): 2889. |
Page 50
| “In 2011, Gary Taubes” |
| G. Taubes. “Is Sugar Toxic?” New York Times Magazine, April 17, 2011. |
| “truth about sugar” |
| R.H. Lustig et al. “The Toxic Truth About Sugar,” Nature 487 (5) (2012): 27. |
| “Joslin Diabetes Center CEO Ron Kahn the question” |
| C.R. Kahn. Can Eating Too Much Sugar Cause My Diabetes? : WebMD, 2015. |
Page 51
Page 52
Page 53
Page 54
| “a war on sugar: is it justified?” |
| S. Dubner. “There’s a War on Sugar. Is It Justified?” In Freakonomics, (Washington, DC: American Public Media), Apr 26, 2017. |
Page 55
Page 56
|
“the American Medical Association to Sunbeam” |
|
“and the ADA to” |
|
M. Santora. “In Diabetes Fight, Raising Cash and Keeping Trust.” New York Times, Nov 25, 2006. |
|
“with $182 million in annual revenues” |
|
“of which 40 percent come from pharmaceutical corporate donations” |
|
“thereby increasing the market” |
|
J.J. Neumiller et al. “Evidence Supports Prediabetes Treatment,” Science 364 (2019): 341. |
|
“the cost of insulin tripled” |
|
“extensive ties with industry, receiving a median” |
Page 57
|
“ADA, for example” |
|
“your privileges” |
|
J. Levine. “The Pros and Cons of Rating Doctors,” AARP Bulletin (2010). |
Page 58
|
“spent in class” |
|
“around the globe” |
|
“fraught with controversy” |
|
“curtail nutritional research” |
Page 59
|
“causative for type 2 diabetes” |
|
“before the intervention” |
Page 60